Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06YWH
|
|||
| Former ID |
DNCL002714
|
|||
| Drug Name |
YM155
|
|||
| Synonyms |
Sepantronium
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65] | Phase 2 | [1] | |
| Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 2 | [1] | ||
| Company |
Astellas Pharma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H19BrN4O3
|
|||
| Canonical SMILES |
CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-]
|
|||
| InChI |
1S/C20H19N4O3.BrH/c1-13-23(9-10-27-2)17-18(24(13)12-14-11-21-7-8-22-14)20(26)16-6-4-3-5-15(16)19(17)25;/h3-8,11H,9-10,12H2,1-2H3;1H/q+1;/p-1
|
|||
| InChIKey |
QBIYUDDJPRGKNJ-UHFFFAOYSA-M
|
|||
| CAS Number |
CAS 781661-94-7
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
16258519, 23368945, 42257948, 49684264, 57376216, 79265296, 126671465, 126731543, 135264254, 135626882, 136367721, 137060252, 152258115, 152344378, 160646954, 160671270, 162133986, 162202717, 164023453, 164194055, 164834152, 174530716, 184811802, 198972028, 223401407, 223681577, 223704842, 227016048, 241383574, 251971032, 252160324, 252216631, 252451818
|
|||
| ChEBI ID |
CHEBI:139608
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00818480) An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.